This past week, Octane and the LaunchPad SBDC Accelerator have contacted our LaunchPad Alumni to determine how they are impacting the community through their technologies. The response was overwhelming, and the Alumni are eagerly willing to help the public through technology, medical advances or donations. The list below is impressive. We thank these companies for demonstrating leadership in their field as we all continue to navigate through this uncertain time.
Aescula Tech
CEO: Niki Bayat
We are currently gearing up in response to the hand sanitizer shortage and will be putting our chemistry skills to work to manufacture and distribute to the LA community. We have already gone through the necessary regulatory and prep work and are excited to help de-throne coronavirus. We will be distributing to high-density and at risk communities so that we can help flatten the curve.
Aequor, Inc.
CEO: Marilyn J. Bruno, Ph.D., J.D
Our health approach to this and other crises: we are working with a major international airport and others on the use of our superior surface cleaners to prevent the spread. These contain ingredients that are EPA-approved and use commercially available chemicals that unlike what is on the market and only lasts until the next contact, lasts over 48 hours.
CBio
CBio is building a point of care, rapid, and portable testing platform for detecting viral load at the single cell level. Our testing platform, cellPhoresis®, will enable affordable multi-time point testing of viral load to allow clinicians to better triage and treat patients.
EM Device Lab, Inc.
President & CEO: Patrick Kolhe
The Quickloop Abscess Treatment Device has been in development for 3 years, has been validated by over 600 clinicians, and is poised to enter the market this summer. The product facilitates the use of the clinically validated Loop Drainage technique, which has been shown to not only reduce {hospital} revisits, but also cut the procedure failure rate in half, further reducing the pressure on the healthcare system. The technique can be learned in less than 5 minutes and can be rapidly adopted.
Gynisus LTD
Founder and CEO: Hila Freidmann
We have created an Infectious Disease Monitor to support medical centers to handle the Coronavirus situation. Through this tool, we provide in-depth and precise epidemiological investigations to the hospitals and medical centers. These real-time and continuous reports are providing the hospitals the direct and indirect exposures to minimize the exposures and making wise managerial and clinical decisions. On top of this information, we provide the severity of illness per patient and connect it to the projections of the hospitalization time, the number of beds in the ICU, etc. so that they will be able to be prepared and minimize the risk. This system is working in New York. We are now working with other medical centers around the world to implement it there.
Gyant
CMO: Alan Young
GYANT is on the forefront of the response, by helping with patient education, navigation and risk identification for COVID. Please see the links below to learn more about what we are helping with. Our tool is free for public use at gyant.com, and open to anyone to experience.
ImmunogenX
CEO: Jack Syage
We have been doing our part by developing some model calculations that we believe are much better than what you are reading in the press and also overcomes shortcomings that the so-called experts are doing. This is not a business venture, but rather a public service.
IntelliStem
CEO: Riam Shamma
Acquired the COVID-19 virus and will be delivering a vaccine for clinical trials in the next few weeks.
LogosE
CEO: Carole Sumner Krechman
We have an initiative way to educate consumers around the world with basic ways to be safe in your home and in the work environment, is video form on our platform. We are planning on 50,000 free downloads on Google and Honeywell beginning next week.
Optify
CEO: Dave Barton
With optometry offices closing we are helping optometrists and their patients shop online. We are now talking to the largest private equity groups right now, as well as independent offices. We are helping them stay in business and consumers get access to glasses without in person contact.
Pandexio
CEO: John Burge
Software solution to help companies more efficiently connect and gather the data they need to review critical information to make decisions on the COVID19 virus.
PatientFi
CEO: Todd Watts
We are sending all PatientFi customers hand sanitizer and made in a compound pharmacy in bulk.
RoundUpToZero
CEO: Patrick Salome
Although we aren’t manufacturing medical equipment or engineering vaccinations, we are donating both our proceeds and our IP to help with fundraising efforts. We’re currently speaking with some government agencies but would love to help local OC government to fundraise through the general public as well.
SMSBioTech
CEO: Abdulkader Rahmo
SMSbiotech is currently working on a therapeutic for COVID-19.
Smudge Labs
SVP Product Development, Smudge Labs: Kolhane Grooters
Creating interactive training tools so that hospital staff can virtually train on ventilators and other equipment being training staff cannot travel at the moment. With all the needs and influx of new equipment intuitive easy to use training is critical.
Synova Life Sciences
CEO: John Chi
The mesenchymal stem cells (MSCs) that we can get from fat are known to have immunomodulatory and anti-inflammatory properties. There are a couple of recent studies done in human patients showing that the MSCs can mitigate the severe respiratory distress in COVID-19, calming down the cytokine storm that leads to respiratory failure with the virus. We’ve been reaching out to some hospitals about doing clinical trials with some of the acute patients – any intros you have along those lines would be greatly appreciated!
Willowglade Technologies Corporation
President & CEO: John Papandrea
Building a Telemedicine module to market that will help with this. Attached is a one pager, and here is a link to a video.
0 Comments